Jaringan Laboratorium Medis

Vol. 6 No. 2 (2024): November 2024
Original Articles

Description of Urea, Uric Acid, Creatinine, and Albumin Levels in MDR-TB Patients Taking OAT at RSP Dr. Ario Wirawan Salatiga

PDF
  • Nurul Qomariyah,
  • Nur Hidayah,
  • Selma Aulia Rahmaddina
Nurul Qomariyah
Poltekkes Kemenkes Semarang
Nur Hidayah
Poltekkes Kemenkes Semarang
Selma Aulia Rahmaddina
Poltekkes Kemenkes Semarang

Published 2024-12-24

Keywords

  • Urea,
  • Uric Acid,
  • Creatinine,
  • Albumin,
  • MDR-TB

Copyright (c) 2024 Jaringan Laboratorium Medis

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Description of Urea, Uric Acid, Creatinine, and Albumin Levels in MDR-TB Patients Taking OAT at RSP Dr. Ario Wirawan Salatiga. (2024). Jaringan Laboratorium Medis, 6(2). https://doi.org/10.31983/jlm.v6i2.12348

CrossMark



Dimensions

If it doesn't Appear, click here



PlumX Metrics



Impact Factor

or, Visit on here

Abstract

Multi Drug Resistant Tuberculosis (MDR-TB) is a type of tuberculosis that is resistant to two first-line antituberculosis drugs (OAT), namely Isoniazid and Rifampicin. MDR-TB treatment involves a combination of first-line and second-line OAT, which is carried out over a long period of time. The prolonged use of these drugs can cause side effects that affect various organs of the body, especially the kidneys. One indication of impaired kidney function is an increase in blood levels of ureum, uric acid, creatinine and albumin. In addition, side effects of drugs such as Kanamycin, which is nephrotoxic, can cause accumulation in the proximal tubules of the kidneys, reduce the glomerular filtration rate, and impact creatinine levels. Another side effect that can arise during MDR-TB treatment is a decrease in appetite, which leads to decreased nutritional intake, reflected in low albumin levels. This study aims to describe the levels of ureum, uric acid, creatinine, and albumin in patients with MDR-TB undergoing treatment at Ario Wirawan Lung Hospital (RSPAW) Salatiga. This study is descriptive qualitative with a cross-sectional approach. Secondary data were collected from the medical record installation from January to December 2023. This study involved 28 respondents, of which 92.86% had normal ureum levels, 71.43% had normal uric acid levels, 96.43% had normal creatinine levels, and 78.57% had normal albumin levels. A small proportion of respondents had elevated ureum or uric acid levels, with some variation in the combination of abnormal creatinine and albumin levels. The conclusion of this study is that although there were patients with abnormal ureum, uric acid, creatinine, or albumin levels, MDR-TB treatment generally did not significantly affect ureum, uric acid, creatinine, and albumin levels in the majority of patients. However, regular monitoring of renal function and nutritional status is still required to detect and manage adverse effects that may arise during long-term treatment.

PDF

Downloads

Download data is not yet available.

References

  1. Aprianto, A., Sudarsono, T. A., Kusuma Wardani, D. P., & Rahaju, M. (2022). Comparison of Ureum and Creatinine Levels in Patients with Pulmonary Tuberculosis in the Treatment Phase 0 and 6 Months. Jurnal Ilmu Dan Teknologi Kesehatan, 10(1), 14–24. https://doi.org/10.32668/jitek.v10i1.927
  2. Bisaso, K. R., Owen, J. S., Ojara, F. W., Namuwenge, P. M., Mugisha, A., Mbuagbaw, L., Luboobi, L. S., & Mukonzo, J. K. (2015). Erratum to: Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy. In Silico Pharmacology, 3(1), 1–8. https://doi.org/10.1186/s40203-014-0005-7
  3. Chuang, Y. M., He, L., Pinn, M. L., Tsai, Y. C., Cheng, M. A., Farmer, E., Karakousis, P. C., & Hung, C. F. (2021). Albumin fusion with granulocyte-macrophage colony-stimulating factor acts as an immunotherapy against chronic tuberculosis. Cellular and Molecular Immunology, 18(10), 2393–2401. https://doi.org/10.1038/s41423-020-0439-2
  4. Djasang, S., & Saturiski, M. (2019). Studi Hasil Pemeriksaan Ureum Dan Asam Urat Pada Penderita Tuberkulosis Paru Yang Mengonsumsi Obat Anti Tuberkulosis (Oat) Fase Intensif. Jurnal Media Analis Kesehatan, 10(1), 59. https://doi.org/10.32382/mak.v10i1.985
  5. Fitriana, S. N., Zulkarnain, B. S., & Yulimanida, H. (2023). Analisis Efek Samping Kanamisin Dan Kapreomisin Terhadap Fungsi Ginjal Pada Pasien Tb Ro Di Rsud Dr. Soetomo. Cendekia Journal of Pharmacy, 7(1), 10–19. https://doi.org/10.31596/cjp.v7i1.195
  6. Kondo, I., Wongkar, M. C. P., & Ongkowijaya, J. (2016). Gambaran Kadar Asam Urat Pada Penderita Tuberkulosis Paru Yang Menerima Terapi Obat Anti Tuberkulosis Di Rsup Prof. Dr. R. D. Kandou Manado Periode Juli 2014 – Juni 2015. E-CliniC, 4(1). https://doi.org/10.35790/ecl.4.1.2016.10980
  7. Muda, I., Adam, M. F., Saputra, R., Muhyi, A., Noprianto, D., & Aminuddin, M. (2023). Association of Multidrug-Resistant Tuberculosis (MDR-TB) Patients on Profile of Liver and Kidney Function. Jurnal Kesehatan Pasak Bumi Kalimantan, 5(2), 139. https://doi.org/10.30872/j.kes.pasmi.kal.v5i2.9640
  8. Nafila, Nurul Haqiqi, R., & Wahyunita, S. (2017). Kadar Asam Urat Pada Penderita Tuberkulosis Dengan Terapi OAT di Puskesmas Cempaka Maret 2017. Jurnal Ilmiah Manuntung, , 3(2), 173–177.
  9. Prasetyo, A. (2019). Tatalaksana Terkini Infeksi Laten Tuberkulosis pada Anak. Cermin Dunia Kedokteran, 46(2), 146–148.
  10. Purba, S. K. R. (2019). Analisa Kadar Ureum Dalam Serum Penderita TB Paru yang Mengkonsumsi Obat Anti Tuberkulosis Lebih Dari 4 Bulan di Laboratorium Prodia Duri. The Indonesian Journal of Medical Laboratory, 1(1), 1–4. http://114.7.97.203:8123/inlislite3/uploaded_files/dokumen_isi/Monograf/12034119_001.pdf
  11. Rahman, A. T., D-III Analis Kesehatan, P., Kesehatan Masyarakat, F., & Indonesia Timur Jl Abdul Kadir No, U. (2020). Pengaruh Lama Waktu Konsumsi Obat Pada Penderita TB Terhadap Kadar Kreatinin dan Ureum diLaboratorium RSUW UIT Makassar 2018. Jurnal Media LAboran , Vol 10. No(November), 48–52.
  12. Reviono, Kusnanto, P., Eko, V., Pakiding, H., & Nurwidiasih, D. (2014). Multidrug Resistant Tuberculosis (MDR-TB): Tinjauan Epidemiologi dan Faktor Risiko Efek Samping Obat Anti Tuberkulosis. Majalah Kedokteran Bandung, 46(4), 189–196. https://doi.org/10.15395/mkb.v46n4.336
  13. Sari, G. K., Sarifuddin, & Setyawati, T. (2022). Tuberkulosis Paru Post Wodec Pleural Efusion: Laporan Kasus Pulmonary Tuberculosis Post Wodec Pleural Effusion: Case Report. Jurnal Medical Profession, 4(2), 174–182.
  14. Sulaiman, S. C., Handayani, L., S.S., M. Y., & Soedarsono, S. (2020). Gambaran Radiografi Tuberkulosis Paru Multidrug-Resistant: Studi Retrospektif di Rumah Sakit Umum Dr. Soetomo Surabaya. Jurnal Respirasi, 4(3), 71. https://doi.org/10.20473/jr.v4-i.3.2018.71-75
  15. Trianziani, S. (2020). View metadata, citation and similar papers at core.ac.uk. 4(November), 274–282.
  16. Ulfah, U. (2022). Gambaran Kadar Asam Urat Pada Penderita Tuberkulosis Paru Yang Mengkonsumsi Obat Anti Tuberkulosis (OAT). Jurnal Kesehatan Rajawali, 11(2), 40–45. https://doi.org/10.54350/jkr.v11i2.108
  17. Ummah, M. S. (2020). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Kemenkes RI, 11(1), 1–156. http://scioteca.caf.com/bitstream/handle/123456789/1091/RED2017-Eng-8ene.pdf?sequence=12&isAllowed=y%0Ahttp://dx.doi.org/10.1016/j.regsciurbeco.2008.06.005%0Ahttps://www.researchgate.net/publication/305320484_SISTEM_PEMBETUNGAN_TERPUSAT_STRATEGI_MELESTARI
  18. Wibowo, W., Mulia, Y. S., Sunarno, S., Su’udi, A., Putranto, R. H., Kusumawati, K., & Renitia, G. I. (2023). Analisis Kadar Ureum, Creatinin, Dan Asam Urat Pada Oat Tb-Paru. Jurnal Riset Kesehatan Poltekkes Depkes Bandung, 15(2), 442–449. https://doi.org/10.34011/juriskesbdg.v15i2.2222
  19. Widyanti, T., Rasiyanto, E., Anita, A., & Mooduto, V. (2021). Studi Literatur Gambaran Hasil Pemeriksaan Ureum Pada Penderita Tuberculosis (Tb) Paru Yang Mengonsumsi Obat Anti Tuberculosis (OAT). Lontara, 2(1), 49–56. https://doi.org/10.53861/lontarariset.v2i1.194
  20. World Health Organization. (2020). Consolidated Guidelines On Tuberculosis Treatment. In Who.
  21. Yosa Mega, J., Keumala Sari, D., & Harahap, J. (2019). Indonesian Journal of Human Nutrition : Korelasi Indeks Massa Tubuh dan Kadar Albumin dengan Konversi Sputum Pasien Tuberkulosis. Indonesian Journal of Human Nutrition, 13, 96–109.